We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$337M
AUM Growth
-$8.73M
Cap. Flow
-$4.66M
Cap. Flow %
-1.38%
Top 10 Hldgs %
36.68%
Holding
216
New
7
Increased
44
Reduced
112
Closed
8

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$732K
2
ELV icon
Elevance Health
ELV
+$644K
3
ADBE icon
Adobe
ADBE
+$573K
4
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$510K
5
NKE icon
Nike
NKE
+$337K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$906K
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$623K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$587K
4
EL icon
Estee Lauder
EL
+$507K
5
GPN icon
Global Payments
GPN
+$433K

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Healthcare 15.23%
3 Financials 13.1%
4 Industrials 8.56%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNI icon
101
Canadian National Railway
CNI
$77.4B
$709K 0.21%
6,988
+90
+1% +$9.85K
ASML icon
102
ASML
ASML
$633B
$707K 0.21%
+1,020
New +$732K
SO icon
103
Southern Company
SO
$109B
$706K 0.21%
8,577
– –
CMCSA icon
104
Comcast
CMCSA
$85.2B
$705K 0.21%
18,782
+426
+2% +$17.7K
FTNT icon
105
Fortinet
FTNT
$117B
$688K 0.2%
7,285
– –
DE icon
106
Deere & Co
DE
$161B
$688K 0.2%
1,623
-6
-0.4% -$2.53K
SOLV icon
107
Solventum
SOLV
$14.8B
$681K 0.2%
10,316
– –
CRM icon
108
Salesforce
CRM
$149B
$667K 0.2%
1,994
-30
-1% -$9.57K
CVS icon
109
CVS Health
CVS
$134B
$647K 0.19%
14,407
-16,156
-53% -$906K
STT icon
110
State Street
STT
$50.7B
$637K 0.19%
6,486
-402
-6% -$38.1K
MDT icon
111
Medtronic
MDT
$109B
$592K 0.18%
7,417
-145
-2% -$12.6K
NFLX icon
112
Netflix
NFLX
$298B
$580K 0.17%
6,510
-50
-0.8% -$4.12K
EBAY icon
113
eBay
EBAY
$50.2B
$567K 0.17%
9,156
-85
-0.9% -$5.4K
VEU icon
114
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$554K 0.16%
9,652
– –
CVX icon
115
Chevron
CVX
$386B
$545K 0.16%
3,766
+10
+0.3% +$1.53K
CI icon
116
Cigna
CI
$74.9B
$542K 0.16%
1,964
-9
-0.5% -$2.87K
BIIB icon
117
Biogen
BIIB
$30.3B
$541K 0.16%
3,536
-148
-4% -$25K
COR icon
118
Cencora
COR
$60.6B
$540K 0.16%
2,403
– –
DG icon
119
Dollar General
DG
$28.1B
$539K 0.16%
7,106
-2,651
-27% -$209K
DUK icon
120
Duke Energy
DUK
$98.3B
$522K 0.15%
4,844
– –
TER icon
121
Teradyne
TER
$58.4B
$517K 0.15%
4,103
+90
+2% +$10.7K
ADBE icon
122
Adobe
ADBE
$98.4B
$514K 0.15%
+1,157
New +$573K
FFIV icon
123
F5
FFIV
$22.8B
$505K 0.15%
2,009
-60
-3% -$14.3K
PSX icon
124
Phillips 66
PSX
$84B
$471K 0.14%
4,137
– –
PEO
125
Adams Natural Resources Fund
PEO
$739M
$470K 0.14%
21,620
+735
+4% +$16.8K
3 4
5
6 7

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Roberts, Glore & Co held 216 positions worth $337M, down 2.5% from $346M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Roberts, Glore & Co's Q4 2024 filing shows 7 new, 44 increased, 112 reduced and 8 closed positions. Its largest new stake was ASML: 1,020 shares worth $707K. The largest sale was CVS Health, an estimated $906K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q4 2024 buy was ASML: 1,020 shares worth $707K.
  • Roberts, Glore & Co added most to Elevance Health in Q4 2024, an estimated $644K increase.
  • Roberts, Glore & Co's biggest Q4 2024 reduction was CVS Health, cutting an estimated $906K.
  • Roberts, Glore & Co fully exited Estee Lauder in Q4 2024, selling an estimated $507K.
  • Roberts, Glore & Co's ten largest holdings make up 37% of its $337M portfolio in Q4 2024.
  • Roberts, Glore & Co opened 7 new positions and closed 8 in Q4 2024.
  • Roberts, Glore & Co's portfolio value fell 2.5% quarter-over-quarter to $337M.

Based on Roberts, Glore & Co's 13F filing for Q4 2024, filed 7 Feb 2025.